Cingulate CINGW
NASDAQ CINGW
$0.01 +0.00 (+4.29%)
As of: Sep 9, 2026 · 11:16 AM EDT

Cingulate (CINGW) Accounts Payables (2021 - 2026)

Cingulate's (CINGW) quarterly Accounts Payables came in at $2.0 million in Q2 2026, down 2.45% quarter-over-quarter from $2.0 million in Q4 2025.

Analysis

Cingulate (CINGW) Accounts Payables (2021 - 2026) Analysis & Trends

Cingulate (CINGW) has reported Accounts Payables for 6 consecutive years, with $2.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Accounts Payables changed N/A year-over-year to $2.0 million; the trailing twelve-month figure through Jun 2026 stood at $2.0 million (changed N/A YoY), and the FY2025 full-year result was $2.0 million, up 60.25% from the prior year.
  • Accounts Payables slipped to $2.0 million in Q2 2026 per CINGW's latest filing, from $2.0 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $5.2 million in Q4 2023 and bottomed at $282265.0 in Q2 2022.
  • Historically, Accounts Payables has averaged $1.3 million across 5 years, with a median of $886230.0 in 2024.
  • The sharpest annual moves came in 2023 and 2024: Accounts Payables soared 581.98% in 2023, then tumbled 75.57% in 2024.
  • Over 5 years, Accounts Payables stood at $762357.0 in 2022, then jumped by 581.98% to $5.2 million in 2023, then sank by 75.57% to $1.3 million in 2024, then jumped by 60.25% to $2.0 million in 2025, then decreased by 2.45% to $2.0 million in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods registered $2.0 million, $2.0 million, and $866245.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 644.46 Bn 623.70 Bn 17.26 Bn 9.22 Bn
2 AbbVie 440.11 Bn 433.54 Bn 12.70 Bn 33.30 Bn
3 Merck 365.04 Bn 357.90 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 266.82 Bn 259.13 Bn 11.24 Bn 4.26 Bn
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn 4.58 Bn
6 Sanofi 52.47 Bn 45.09 Bn 10.79 Bn 8.31 Bn
7 Revolution Medicines 44.26 Bn 44.26 Bn - 88.42 Mn
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn 250.40 Mn
9 United Therapeutics 21.46 Bn 18.80 Bn 683.80 Mn 497.80 Mn
10 Cingulate 100,214.03 100,214.03 - 1.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.99 Mn
Dec 31, 2025 2.04 Mn
Sep 30, 2025 866,245.00
Mar 31, 2025 855,150.00
Dec 31, 2024 1.27 Mn
Sep 30, 2024 906,215.00
Jun 30, 2024 1.33 Mn
Mar 31, 2024 737,949.00
Dec 31, 2023 5.20 Mn
Sep 30, 2023 1.67 Mn
Jun 30, 2023 1.61 Mn
Mar 31, 2023 599,033.00
Dec 31, 2022 762,357.00
Sep 30, 2022 392,798.00
Jun 30, 2022 282,265.00
Mar 31, 2022 556,326.00
Dec 31, 2021 264,687.00